IL-21

IL-21

IL-21 분자 정보

Molecule Name
Interleukin-21
분자 별명
IL21,Za11,Interleukin-21
Drug Development Progress
임상 약물 수4
시판 약물 수0
최고 연구 개발 단계Phase 2 Clinical
표적 별명
Za11,IL-21,CVID11,Interleukin-21 Isoform,Interleukin 21
분자 배경
Interleukin-21 (IL-21) is a secreted protein which belongs to the IL-15 / IL-21 family. Interleukin-21 / IL-21 belongs to a family of cytokines that bind to a composite receptor consisting of a private receptor (IL21R) and the common cytokine receptor gamma chain (gamma(C)). Interleukin-21 / IL-21 impacts a number of cell types, including CD8+ memory T cells, NK cells and subsets of CD4 memory T cells. The IL-21R is widely distributed on lympho-haematopoietic cells. IL-21 is a pleiotropic cytokine produced by CD4+ T cells in response to antigenic stimulation. Its action generally enhances antigen-specific responses of immune cells. IL-21 promotes the anti-tumor activity of CD8+ T-cells and NK cells. IL-21 exerts its effect through binding to a specific type I cytokine receptor, IL-21R, which also contains the γ chain (γc) found in other cytokine receptors including IL-2, IL-4, IL-7, IL-9 and IL-15. The IL-21/IL-21R interaction triggers a cascade of events which includes activation of the tyrosine kinases JAK1 and JAK3, followed by activation of the transcription factors STAT1 and STAT3.

IL-21 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
CVD-1301.V01hV-01; CVD-1301.V01; V 01Phase 2 ClinicalHangzhou Converd Co Ltd
Pancreatic Neoplasms; Sarcoma 180; Solid tumours; Uterine Cervical Neoplasms
상세
IL-21 mab (Lilly)Phase 1 ClinicalEli Lilly And Company
Immune System Diseases
상세
triple anti-CD19 CAR T-cell therapy/PD-1 checkpoint inhibitor/IL-21 receptor agonist (CD (Suzhou) Biopharma/Chinese People's Liberation Army General Hospital/Chinese academy of sciences)Phase 1 ClinicalChinese Academy Of Sciences
Hematologic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
CD-001CD-001Phase 1 ClinicalCD (Suzhou) Biopharma Co Ltd
Head and Neck Neoplasms; Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Solid tumours
상세